Immune classifications with cytotoxic CD8⁺ and Th17 infiltrates are predictors of clinical prognosis in glioblastoma

Abstract

Our study shows that glioblastoma bearing patients can be classified on the immune infiltrate aspects. Beyond this prognostic role of immune biomarkers, subsequent classifications could definitely help clinicians to handle targeted therapy administration and immunotherapeutic interventions.